Premier Biomedical Inc (PK:BIEI)

Business Focus: Biotechnology & Medical Research

Jul 30, 2019 10:00 am ET
Premier Biomedical Signs Joint Venture Agreement With New Earth Development, RushNet Inc., and XYZ Hemp, Inc. to Market New Anti-Addiction Patch
JACKSON CENTER, PA / ACCESSWIRE / July 30, 2019 / Premier Biomedical, Inc. (OTCQB: BIEI) announced today the signing of an agreement forming a joint venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc. to manufacture, market and sell a revolutionary Anti-Addiction Patch contain
Feb 20, 2019 08:30 am ET
Uptick Newswire Hosts Premier Biomedical, Inc. on The Stock Day Podcast to Discuss the Company’s Current Projects
Uptick Newswire Stock Day Podcast welcomed Premier Biomedical, Inc. (BIEI), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William A....
Dec 20, 2018 07:30 am ET
Uptick Newswire Hosts the CEO of Premier Biomedical, Inc. to Talk About Exciting Deals on the Horizon with Distributors and the Launch of New Products in 2019
Uptick Newswire Stock Day Podcast features Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases, which has expanded into...
Dec 06, 2018 08:00 am ET
Premier Biomedical Signs Agreement With CBD HEMP Distributing Company to Distribute Premier’s Topical Pain Relief Products In Four Northeastern States
JACKSON CENTER, PA / ACCESSWIRE / December 6, 2018 / Premier Biomedical, Inc (OTC: BIEI) a research based publicly traded biomedical company has signed a sales and distribution agreement with CBD Hemp Distributing Company, a newly formed company part of a conglomerate.The company, whose members have an extensive network of sales contacts in the retail pharmaceutical and pain management medical industry, will have exclusive distribution rights to Premier Biomedical's topical pain re
Oct 31, 2018 08:00 am ET
Premier Biomedical, Inc. CEO Letter - October, 2018
Greetings from the CEO and Staff at Premier Biomedical!
Oct 29, 2018 09:00 am ET
Premier Biomedical, Inc.’s CEO Discusses a Bright Future for His Company and All-Natural Solutions with Uptick Newswire’s Stock Day Podcast
Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases. and provide all-natural, 50-state-legal topical pain relief...
Oct 26, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 10/26
LOS ANGELES, CA / ACCESSWIRE / October 26, 2018 / Crowdfunding, cannabis payments, disruptive water company, CBD pain relief, protecting consumers, new civil war; this week on MoneyTV with Donald Baillargeon.
Oct 17, 2018 04:01 pm ET
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
NEW YORK, Oct. 17, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the third quarter 2018 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index. ...
Oct 02, 2018 08:30 am ET
Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast
Premier Biomedical, Inc. (OTCQB:BIEI) (“Premier Biomedical, Inc.” or the “company”) is looking for new strategies and joint ventures to sell CBD. CEO and President of Premier Biomedical, Inc., William A. Hartman, talked with Stock Day’s Everett...
Aug 28, 2018 08:00 am ET
ICYMI - Premier Biomedical CEO Interviewed on Money TV
In Case You Missed It - Mr. Hartman Discusses Recent Accomplishments and New Opportunities
Aug 27, 2018 08:30 am ET
Premier Biomedical, Inc. President and CEO William Hartman Discusses Company Updates Since July 2018 and Their 250:1-Split with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
Premier Biomedical, Inc. (OTCQB:BIEI) (the “Company”), announced President and CEO William A. Hartman’s interview on Uptick Newswire’s “Stock Day” Podcast. Everett Jolly began the interview by welcoming back Premier Biomedical, Inc. President and...
Aug 27, 2018 08:30 am ET
Premier Biomedical, Inc. President and CEO, William Hartman Discusses Company Updates Since July 2018 and Their 250:1-Split with Everett Jolly on Uptick Newswire's ''Stock Day'' Podcast
JACKSON CENTER, PA / ACCESSWIRE / August 27, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI) (the "Company") announced President and CEO, William A. Hartman's interview on Uptick Newswire's "Stock Day" Podcast.
Aug 24, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 8/24
LOS ANGELES, CA / ACCESSWIRE / August 24, 2018 / Logistics, self-driving cars, water conference, CBD, cannabis, Unhappy Meals; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Aug 21, 2018 08:00 am ET
Premier Biomedical, Inc. Creates Four Centers of Technological Expertise
JACKSON CENTER, PA / ACCESSWIRE / August 21, 2018 / Premier Biomedical, Inc. (OTCQB: "BIEI"), a research based publicly traded biomedical company, announced that it has created four interrelated centers of technological expertise. The centers identified include:
Aug 15, 2018 08:00 am ET
PainReliefMeds.com Resumes Credit Card Processing
Issues Related to the Suspension of Credit Card Processing Have Been Resolved
Aug 07, 2018 08:00 am ET
Premier Biomedical Signs Agreement With Sales Group to Represent Premier's Topical Pain Relief Products to the Military
Group Has Extensive Experience and Connections Within Military and Government Procurement Organization
Jul 30, 2018 08:00 am ET
Premier Biomedical, Inc. Uplifted to OTCQB
BIEI Trading on OTCQB Effective July 27, 2018
Jul 18, 2018 01:17 pm ET
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
William Hartman, CEO of Premier Biomedical Inc. (OTC PINK:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast. Premier Biomedical currently consists of two groups: The Biologics Group deals fundamentally with the...
Jul 10, 2018 08:00 am ET
Premier Biomedical, Inc. Ceo Letter - July, 2018
JACKSON CENTER, PA / ACCESSWIRE / July 10, 2018 / Greetings From The CEO And Staff At Premier Biomedical!
Jun 27, 2018 08:00 am ET
Premier Biomedical, Inc. Effects Reverse Split
FINRA Approves BIEI 250:1 Reverse Stock Split Effective June 27, 2018
Jun 08, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 6/8
LOS ANGELES, CA / ACCESSWIRE / June 8, 2018 / CBD-based pain relief, bitcoin trading academy, 3D medical imaging, electronic payments, the power of THEY; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Jun 04, 2018 08:00 am ET
Premier Biomedical's CEO, William A. Hartman, Visits Uptick Newswire's "Stock Day" with Marcus Heatherly
JACKSON CENTER, PA / ACCESSWIRE / June 4, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI) President & CEO, William A. Hartman was recently interviewed by Marcus Heatherly on Uptick Newswire's "Stock Day" podcast. He discussed the company's history, recent participation in the Sorinex Summer Strong event, the science behind their CBD-based products, and exciting plans for the company's future.
Jun 04, 2018 08:00 am ET
Uptick Newswire Welcomes William Hartman, CEO of Premier Biomedical, Inc. Back on to the “Stock Day” Podcast
William Hartman, CEO of Premier Biomedical, Inc. (OTC Pink:BIEI) (“the Company”) was recently interviewed by Marcus Heatherly on Uptick Newswire’s “Stock Day” podcast. He discussed the company’s history, recent participation in the Sorinex Summer...
May 25, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 5/25
LOS ANGELES, CA / ACCESSWIRE / May 25, 2018 / Spirits industry, CBD, cryptocurrrency, cannabis, Swamp-Gate; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
May 18, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 5/18
LOS ANGELES, CA / ACCESSWIRE / May 18, 2018 / Legal sports betting, pain relief, cryptocurrency, blockchain, CBD; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Apr 26, 2018 08:30 am ET
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTCBB:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to discuss recent company developments.
Apr 25, 2018 08:00 am ET
Premier Biomedical, Inc. CEO Letter - April 2018
JACKSON CENTER, PA / ACCESSWIRE / April 25, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI);
Apr 13, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 4/13
LOS ANGELES, CA / ACCESSWIRE / April 13, 2018 / Pain relief, cancer treatment, blockchain and cryptocurrency, water cleanup, cannabis business, organic teas, US/China trade war; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Mar 29, 2018 08:00 am ET
ICYMI - Premier Biomedical CEO Interviewed on MoneyTV
In Case You Missed It - Mr. Hartman Recaps the Company's History and Plans for the Future
Mar 23, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 3/23
LOS ANGELES, CA / ACCESSWIRE / March 23, 2018 / Pain relief, medical imaging, water cleanup, cannabis business, solar and roofing, cloud, blockchain, Facebook; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Mar 09, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 3/9
LOS ANGELES, CA / ACCESSWIRE / March 9, 2018 / Blockchain, water cleanup, cannabis business, Chinese investors, cancer treatment, medical imaging; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Mar 02, 2018 05:00 am ET
MoneyTV with Donald Baillargeon, 3/2
LOS ANGELES, CA / ACCESSWIRE / March 2, 2018 / CBD oil, the blockchain, water cleanup, solar and roofing, cannabis business, Chinese investors, who want the POTUS job; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.
Feb 28, 2018 08:00 am ET
Premier Biomedical Inc. Searching For Development Partner To Advance Patent Pending Technology
Jackson Center, PA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC: "BIEI") announced today they are actively searching for a partner to develop their patented extracorporeal treatment process in combination with their patent pending method for...
Feb 21, 2018 08:00 am ET
Premier Biomedical Inc., CEO William Hartman Returns to Uptick Newswire’s “Stock Day” with Everett Jolly
PHOENIX, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical Inc., (OTC:BIEI) President & CEO, William A. Hartman today reviewed operational accomplishments of 2017 and expectations for 2018 in an interview on Uptick Newswire’s “Stock Day” podcast with Everett...
Feb 20, 2018 08:00 am ET
Premier Biomedical Pain Relief Products Now Sold Through Okeechobee Discount Drugs
JACKSON CENTER, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced today they have signed a distribution agreement with Okeechobee Discount Drugs to sell and distribute Premier’s pain relief products.  This agreement will make Premier’s...
Feb 12, 2018 10:00 am ET
Anti-Aging Patent Application Filed; Exclusive Commercial Rights to Premier Biomedical, Inc.
JACKSON CENTER, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced today the filing of a patent application, “Method For Slowing The Aging Process”, by Mitchel S. Felder, MD, the Chairman of the Board and...
Feb 05, 2018 08:21 am ET
ICYMI - Premier Biomedical CEO Interviewed on Fox Business “New To The Street” Program
In Case You Missed It – Mr. Hartman recaps the Company’s history and outlook
Jan 26, 2018 08:00 am ET
Premier Biomedical, Inc. CEO Letter -- January, 2018
DALLAS, Jan. 26, 2018 (GLOBE NEWSWIRE) --
Jan 23, 2018 10:25 am ET
Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment
Brings To Five The Number Of Products Introduced In First Twelve Months
Jan 17, 2018 10:31 am ET
Premier Biomedical Updates “Stock Day” Listeners on 2017 Accomplishments; Sketches Outline Towards $5 Billion CBD Oil Market Penetration
PHOENIX, Jan. 17, 2018 (GLOBE NEWSWIRE) -- The Uptick Newswire “Stock Day” podcast keeps investors up to date on the latest penny stock news by bringing transparency in the micro-cap side of the market. Connect with “Stock Day”...
Jan 11, 2018 08:00 am ET
Premier Biomedical and HealthWarehouse Team Up to Fight Opioid Pain Medication Abuse
Enter Agreement for Sales, Marketing and Distribution of Opioid-Alternative Topical Pain Relief Products
Dec 22, 2017 01:10 pm ET
Nov 20, 2017 08:00 am ET
Premier Biomedical’s CEO, William A. Hartman, Returns to Uptick Network “Stock Day” for an Update on Latest Company Developments
Dallas, TX, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire announces the return of Mr. William A. Hartman, President & CEO of Premier Biomedical Inc. (OTCQB: BIEI, the “Company”) on the Uptick Network “Stock Day" Podcast. Mr. Hartman overviewed...
Nov 16, 2017 10:00 am ET
Premier Biomedical Appoints Carl Eller, NFL Retired Players Association President, as Marketing & Planning Vice-President
El Paso, Texas, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: "BIEI") announced the appointment of retired NFL Pro Football Hall of Famer, Carl Eller, to the post of Marketing and Planning Vice-President.  Mr. Eller, a...
Jul 17, 2017 07:00 am ET
Premier Biomedical, Inc. CEO Letter July 2017
Greetings From The CEO and Staff at Premier Biomedical (OTCQB: BIEI)
Jul 13, 2017 10:00 am ET
Premier Biomedical Integrates CBD-Based Pain Relief Products Business; Expands Current and New Product Offerings
Premier Biomedical, Inc. (OTCQB: BIEI) announced today they have terminated the joint venture, Premier Biomedical Pain Management Solutions LLC, which was formed in September of 2016. Premier Biomedical has integrated the pain relief products business into a division of Premier, which will continue to develop and market an expanded array of natural and synthetic, 50-state legal CBD-based, generalized, neuropathic, and localized pain relief treatment products. Their products will continue to be sold through their website, www.painreliefmeds.com, as well as through an expanding network of
Jul 10, 2017 11:30 am ET
Premier Biomedical Introduces Improved Topical Skin Products
Premier Biomedical, Inc. (OTCQB: BIEI) announced today that it has reformulated its CBD Hemp Oil 96-hour Skin Patch and oil-based CBD Hemp Oil Roll-on to provide more of the active ingredient, CBD. The skin patch is increasing its CBD content to 50 mg, while maintaining its current selling price of $20. Roll-on applicators are currently available in two forms -- 110 mg CBD oil-based with sage scent, and 120mg CBD water-based lavender scent. A new, stronger oil-based sage scented roll-on with 150mg of CBD will be available by the end of the third quarter. These higher content CBD products will
Jun 29, 2017 10:00 am ET
Premier Biomedical Launches Volume Manufacture of Topical Pain Relief Products Enabling Significant Expansion of Business
Premier Biomedical, Inc. (OTCQB: BIEI) announced today that it has reached agreement with SinglePoint (OTC: SING) to manufacture Premier's new-design CBD Hemp Oil Patch in high volume. SinglePoint is a diversified company with numerous subsidiaries involved in various aspect of the cannabis industry from growers to retail outlets. Launching volume manufacture of its products allows Premier to begin aggressively expanding their distribution network through retail outlets, healthcare facilities, pharmacies, and various on-line shopping platforms.
Jun 27, 2017 08:30 am ET
SinglePoint Expects Significant Revenues Increase as Cannabis Subsidiary Receives Initial Payment for New Major Purchase Order
SinglePoint (OTC: SING) announces that its recently acquired DIGS Hydro subsidiary has received a major purchase order from Premier Biomedical (OTCQB: BIEI). DIGS Hydro has received the initial payment with final payment due on delivery. Based on recent discussions between the parties, Premier Biomedical plans to continue to order its supplies from DIGS Hydro, a provider of a variety of supplies and services specifically to the cannabis industry.
Apr 11, 2017 10:00 am ET
Premier Biomedical, Inc. CEO Letter - April, 2017
Premier Biomedical, Inc. (OTCQB: BIEI)
Mar 02, 2017 10:15 am ET
Premier Biomedical Retires Convertible Debt
Premier Biomedical, Inc. (OTCQB: BIEI) announced today that the principal amounts on their outstanding convertible debts have been retired. The company acknowledged that, although it still needs capital to keep the business going, they will be more judicious in any future financing.
Feb 15, 2017 11:11 am ET
Multi-Pronged Product Distribution Agreements Announced by Premier Biomedical Pain Management Solutions for Their Superior Pain Relief Products
Premier Biomedical, Inc. (OTCQB: BIEI) announced today their joint venture, Premier Biomedical Pain Management Solutions, LLC (PBPMS), has signed distribution agreement contracts with multi-state pharmacies to sell and distribute PBPMS pain relief products. These outlets augment PBPMS's existing internet sales through their website, www.painreliefmeds.com, and other direct outlets announced in earlier press releases. Initially, the distribution contracts cover pain relief patches and roll-ons, but will expand as planned new products are introduced later this calendar year.
Jan 18, 2017 10:15 am ET
Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products
Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has signed a distribution agreement contract with the Pain Relief & Wellness Strategy Center in Grove City, Pennsylvania to sell and distribute its pain relief products. Initially, the contract will cover pain relief patches and roll-ons, but will expand as new products are introduced.
Dec 15, 2016 08:00 am ET
Premier Biomedical, Inc. CEO Letter - December, 2017
Premier Biomedical, Inc. (OTCQB: BIEI)
Dec 06, 2016 08:00 am ET
Premier Biomedicals Research on its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer
Premier Biomedical, Inc. (OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as potential novel therapies for pain management, announced today that a paper describing their groundbreaking metronomic cancer therapy work in conjunction with development of a patent pending CTLA4 anti-cancer antibody drug at the University of Texas El Paso (UTEP) has been accepted for publication by the prestigious British Journal of Cancer.
Nov 16, 2016 08:00 am ET
Premier Biomedical Pain Management Solutions Reports Outstanding Results in Pre-Production Pain Patch Trials Conducted by Medical Professionals
Premier Biomedical, Inc. (OTCQB: BIEI) a biotechnology R&D public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as non-narcotic, all-natural-ingredient, 50-state legal, novel pain management therapies, announced today the early results from users of their pain patch samples. Patients who have been given the patch have reported significant or complete relief of their pain for multiple-days with no reported side-effects. Here is just a sample of their
Nov 09, 2016 08:00 am ET
Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017
Premier Biomedical, Inc. (OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as non-narcotic, all-natural-ingredient, 50-state legal, novel pain management therapies, announced today that the management team from their Pain Management Division will attend an upcoming cannabis business conference & expo, November 15-18, 2016 in Las Vegas. This conference is the longest running, most respected cannabis industry conference,
Oct 06, 2016 07:00 am ET
Sep 27, 2016 10:00 am ET
Premier Biomedical Pain Management Solutions Announces Shipment of Initial Samples of Opioid-Free, 50-State Legal, CBD-Based Pain-Relieving Topical Patch
Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has manufactured and shipped initial design sample pain relieving topical patches for distribution to select VA hospital patients, military personnel, doctors, and professional sports figures. These patent-pending, opioid- and narcotic-free all-natural-ingredient topical pain relief patches consist of a proprietary mechanism for extended delivery of their cannabis-based medical CBD pain relieving compound, which is legal in all 50 states.
Sep 15, 2016 10:00 am ET
Premier Biomedical and Advanced Technologies Solutions Form Pain Management Joint Venture to Treat Generalized, Neuropathic and Localized Pain With Natural Cannabis-Based Products
Premier Biomedical, Inc. (OTCQB: BIEI) announced today the signing of an agreement forming a joint venture company with Advanced Technologies Solutions (ATS), a San Diego, California enterprise. The joint venture company, Premier Biomedical Pain Management Solutions, LLC, will develop and market natural and cannabis-based generalized, neuropathic, and localized pain relief treatment products. Sales for the initial product, an extended-duration topical patch, are expected in early 2017, with a variety of follow-on opioid-free pain relief products launching soon thereafter. Sample pain
Aug 22, 2016 08:00 am ET
Premier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical Officer
Premier Biomedical, Inc. (OTCQB: BIEI) announced the appointment of Dr. Patricio F. Reyes to its Board of Directors and to the position of Chief Technical Officer (CTO) effective immediately. He will report to Premier's President and CEO, William A. Hartman. As Chief Technical Officer, Dr. Reyes fills the vacancy recently created by the untimely passing of Dr. James Frincke. Our condolences go out the family of Dr. Frincke.
Aug 01, 2016 08:00 am ET
Premier Biomedical and Advanced Technologies Solutions Agree to Forming Joint Venture in Pain Management, Treating Neuropathic and Localized Pain
Premier Biomedical, Inc. (OTCQB: BIEI), a biotech research public company, and Advanced Technologies Solutions (ATS), a leader in natural ingredient pain relief compounds and delivery technologies, announced the signing of a Letter of Intent (LOI) to form a Joint Venture (JV) to manufacture and distribute products to treat neuropathic and other localized pain. The formation of this joint venture is expected to expedite the development of a series of topical and oral opioid-free pain treatments to compete in the $40 billion pain management segment of the U.S. healthcare market.
Jul 06, 2016 08:00 am ET
Premier Biomedical Anti-Cancer Antibody Outperforms Leading Multi-Billion Dollar Commercial Cancer Treatments in Initial Head-to-Head Testing at a Major University
Premier Biomedical, Inc. (OTCQB: BIEI) announced today the favorable results of initial multi-faceted mouse testing of their patent pending anti-cancer antibody versus commercially available competitive drugs. The Premier Biomedical antibody, PBI-5D3H5, demonstrated superiority based on tumor volume and mouse survivability.
May 31, 2016 12:00 pm ET
Premier Biomedical Confirms Consolidation of Debt
Premier Biomedical, Inc. (OTCQB: BIEI) reported today that it has consolidated its debt to one lender, a move that the company believes will minimize the toxic impact that having multiple lenders had on the market for its stock.
May 24, 2016 02:19 pm ET
Premier Biomedical Announces the Appointment of Dr. James Frincke to Chief Technical Officer Position
Premier Biomedical, Inc. (OTCQB: BIEI) announced the appointment of Dr. James Frincke to the position of Chief Technical Officer effective immediately. In this role, Dr. Frincke will report to the President and CEO of Premier, William A. Hartman. Dr. Frincke will retain his current position as a member of the company's Scientific Advisory board, which reports to Premier's co-founder and Chairman of the Scientific Advisory Board, Dr. Mitchell S. Felder, MD.